Home » Health »

FDA reveals five dead after anti-obesity balloon surgery

 
  • Five people fitted with anti-obesity balloon devices have died since 2016
  • The FDA disclosed the cases in an alert to doctors of patients with similar devices
  • Three of the patients died within three days, the other two within a month 
  • Four of the patients were using the Orbera Intragastric Balloon System made by Apollo Endo Surgery, the fifth was ReShape Medical Inc’s device

Maggie O’neill For Dailymail.com

27

View
comments

Five people have died after have anti-obesity devices surgically inserted into their stomachs, US regulators have revealed.

The patients all went under the knife earlier this year to get FDA-approved liquid-filled balloons fitted in a bid to lose weight.

But three of the five patients died within three days of their supposedly low-risk operation. The other two died within a month. 

The FDA said it is not clear whether the deaths were caused by the devices – which were approved in 2015 – or the surgical process. 

However, the agency has issued a warning to doctors treating patients with similar devices to monitor them closely.

Since 2016 five people who have had balloons inserted into their stomachs to treat obesity have died. The FDA does not know if the deaths were caused by the devices themselves or the insertion surgeries (file photo)

Since 2016 five people who have had balloons inserted into their stomachs to treat obesity have died. The FDA does not know if the deaths were caused by the devices themselves or the insertion surgeries (file photo)

Since 2016 five people who have had balloons inserted into their stomachs to treat obesity have died. The FDA does not know if the deaths were caused by the devices themselves or the insertion surgeries (file photo)

Four of the patients were using the Orbera Intragastric Balloon System, made by Apollo Endo Surgery. The fifth was using the ReShape Integrated Dual Balloon System, made my ReShape Medical Inc.

The Orbera balloon, approved in August 2015, is filled with saline and inserted in an obese patient’s stomach to help them with portion control.

Apollo Endo Surgery said there have been more than 220,000 cases of successful Orbera placements across 80 countries.

The company said the product can help overweight people lose more than three times the weight that diet and exercise alone can.

The ReShape balloon, approved by the FDA in June 2015, is inserted into a patient’s stomach via their mouth to prevent surgical scarring.

The FDA warned that someone who has already had gastrointestinal surgery or who is ‘unwilling or unable to participate in a medically-supervised diet and behavior modification program’ should not try either of the devices.

Apollo said in a press release that the deaths of the patients using their weight-loss balloon were not necessarily caused by their products.

‘The FDA’s letter to health care providers does not indicate that the patient deaths were related to the Orbera device or the insertion procedures.

‘While the cause of death has not been provided or determined in all cases, Apollo has not received any communication or indication from the attending physicians or hospitals that the deaths have been due to the Orbera device.’

The company has not received product-liability claims as a result of any of the deaths, it said.

They said that from January 2006 to March 2017, 21 patients using the Orbera device died. 

This is less than 0.01 percent of the more than 277,000 Orbera balloons distributed during that time period, their statement said.

Apollo’s CEO Todd Newton said many of the patients who use the device as a weight-loss tool have other obesity-related health problems.

‘The FDA letter is an important reminder to the physician community that obesity is a serious disease and many obese patients are affected by one or more co-morbid conditions due to their obesity.’

Comments 27

Share what you think

The comments below have not been moderated.

The views expressed in the contents above are those of our users and do not necessarily reflect the views of MailOnline.

Close

Your comment will be posted to MailOnline as usual.

 

Close

Your comment will be posted to MailOnline as usual

We will automatically post your comment and a link to the news story to your Facebook timeline at the same time it is posted on MailOnline. To do this we will link your MailOnline account with your Facebook account. We’ll ask you to confirm this for your first post to Facebook.

You can choose on each post whether you would like it to be posted to Facebook. Your details from Facebook will be used to provide you with tailored content, marketing and ads in line with our Privacy Policy.

 

Related Posts

  • No Related Posts